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ABSTRACT
Over 250,000 people in the United States currently live with a spinal cord injury
and approximately 11,000 new cases occur every year. People with spinal cord injuries
experience a significant reduction in quality of life due to the many problems that arise
from damage to the spinal cord including paralysis and loss of sensation below the
location of injury, loss of bowel and bladder function, loss of sexual function, and
impaired respiration. Despite considerable ongoing research in the area of nerve
regeneration by various institutions, satisfactory treatment for spinal cord injury has not
yet been discovered.
Previous studies have had considerable success in facilitating the regeneration of
severed peripheral nerves through the use of collagen based implants used to bridge the
resulting gap between the severed nerve stumps. The current study aims to apply this
same regenerative approach to a defect created in the spinal cord of adult rats. The
objective is to evaluate the efficacy of three different collagen implants toward the
regeneration of the spinal cord. The experimental spinal cord injury was a complete
transection at T7 and T9 and the removal of the spinal cord segment between the two
transections, creating a 5 mm gap.
This study contained four experimental groups. Group I was the control group.
The animals in this group had a complete spinal cord transection as described above but
received no implantation. Group II received a resorbable dura replacement sheet of
collagen, 1 mm thick, cut from the BioGide@ membrane which was placed extradurally
over the dorsal aspect of the wound site. Group III used the BioGide® membrane as a
wrap which bridged the gap between the two cord stumps. Group IV used a collagen
tube, fabricated using a freeze-drying process, to bridge the gap.
Histological analysis at 6 weeks after implantation showed Groups III and IV to
have more longitudinally oriented reparative tissue filling the defect area as well as fewer
fluid-filled cysts. Quantitative analysis of axonal regeneration showed the collagen
implants to be supportive of the regeneration of axons into the center of the defect.
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Professor of Orthopedic Surgery (Biomaterials), Harvard Medical School
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Chapter 1: Introduction
1.1 Motivation of Research
There are currently 250,000 people in the United States who have suffered a
spinal cord injury and there are approximately 11,000 new cases every year. Motor
vehicle crashes account for the majority of new spinal cord injury (SCI) cases. The most
common neurologic level of injury is tetraplegia (57.6% for both complete and
incomplete injuries) followed by paraplegia (35.9% for both complete and incomplete
injuries). Only less than 1% of patients with SCI experience full neurological recovery
[1].
Patients with SCI often suffer significant reduction in quality of life. In addition
to suffering paralysis and the loss of sensation below the level of injury, other basic
bodily functions are often impaired including breathing, bowel and bladder control and
sexual function. As a result, sufferers of spinal cord injuries lose a great deal of their
independence. Additional complications that often arise with SCI are orthostatic
hypotension, autonomic dysreflexia, osteoporosis, chronic pain, and pressure ulcers [2].
The financial toll that SCI imposes is quite staggering. Lifetime costs that are
directly attributed to SCI vary depending on the severity of injury and are as high as $2.8
million for high tetraplegia and $900,000 for paraplegia [1].
1.2 The Nervous System
The nervous system is composed of a network of cells, or neurons, which are
distributed throughout the body and function to transmit information as electrochemical
impulses to and from and within the brain. Some of the information that is transmitted
via the neural network is in response to stimuli received from both the external and
internal environment of the body (sensory information), while other information
transmitted by neurons is in the form of motor commands which cause muscles to
contract or glands to function.
The cells of the central nervous system include neurons (which transmit
information) and glia, which support neuronal function.
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The nervous system is comprised of various types of neurons which reside in
different parts of the nervous system. The varying types of neurons have different sizes,
shapes, and functional roles. However, all neurons have a least one axon and one or
more dendrites. Neurons can be categorized into three basic types. Unipolar neurons
have a spherical cell body with a single process that divides into two branches (Figure
1.1A). Bipolar neurons are spindle shaped and have 2 processes (Figure 1 .1B).
Multipolar neurons, as their name suggests, have numerous processes coming from the
cell body (Figure 1.1C) [3].
A B C
Somna (cell
Dendrite
Dendrites Dendrites
Soma
Soma
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Axon Axon myelln sheath Myelin Terminal
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TrnaDirection of
Terminalmesg
Buttons
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Figurel.1 - (A) Unipolar neuron. (B) Bipolar neuron. (C) Multipolar neuron.
Key features of a neuron are the cell body - containing the nucleus and numerous
xonm Men S,.h organelles, the axon, and the dendrites. The axon
of a neuron is connected to the cell body and
departs from a location known as the axon hillock.
It is the process of a neuron by which impulses
o g are transmitted. Unlike the cell body, axons do
not have any structures associated with protein
Schwann synthesis or assembly. Axons vary in length, and
" * "0 can be up to a meter long in the spinal cord of
(b) 0adult humans. Axons have a cylindrical shape
Figure 1.2 - (a) Illustration of axon and can be either myelinated or unmyelinated.
myelination by oligodendrocyte. (b)
Illustration of axon myelination by
Schwann cell.
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Myelation occurs when axons become wrapped in multiple layers of Schwann or
oligodendroglia plasmalemma (Figure 1.2). The myelin sheets serve as electric
insulation to the axons and improve electrical conduction. Myelinated axons conduct
nerve impulses at a faster rate than unmyelinated axons.
IL~ I
axon
Figure 1.3 - A neural synapse.
Another important part of a neuron is the
dendrite. Dendrites contain sites for synaptic contact
with axon terminals from other neurons. This site of
contact between neuronal cells is called the synapse.
Figure 1.3 gives an illustration of a neural synapse.
The transmission across a synapse occurs through
the release of neurotransmitters by the presynaptic
neuron, followed by the diffusion of the molecules
across the synaptic cleft, and culminating with the
binding of the molecules to receptors on the
postsynaptic membrane. The neurotransmitter causes
a change in the permeability of the cell membrane to certain ions. For the transmission of
an electric impulse the change of permeability of the membrane allows for the influx of
sodium ions and the efflux of potassium ions, resulting in a localized reversal of charge
of the cell membrane causing a propagation of an action potential [4]. In myelinated
Capillary
End-foot
rocyte
Neuron
Figure 1.4 - Astrocyte in close proximity of a
neuron and capillary.
axons, electric impulses jump from one node
of Ranvier to another. The nodes of Ranvier
are the small areas of myelin discontinuity
along the length of the axon. These areas of
myelin discontinuity occur between the
myelin coverage of one oligodendrocyte or
Schwann cell and another.
Neuroglia, the supporting cells of the
nervous system, include astrocytes,
oligodendrocytes and Schwann cells,
ependymal cells, and microglia. Astrocytes
are starlike cells and are the largest of the
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neuroglia. Astrocytes have numerous processes which attach to the outer surface of
capillaries. Fibrous astrocytes are involved with the repair of damaged tissue (they
produce scarring) and are found primarily within the white matter. They help facilitate
the metabolite transfer to neurons. Protoplasmic astrocytes are very closely associated
with neurons and can partially envelop them. They are found mainly in the gray matter
of the brain and spinal cord. Figure 1.4 illustrates the close association of astrocytes with
neurons and capillaries.
Oligodendrocytes are commonly located among strands of axons and serve to
myelinate axons. A single oligodendrocyte can myelinate numerous axons as is
illustrated in Figure 1.5. Oligodendrocytes can be found in both the grey and white
matter.
Myefinated axons
Node of
Ranvier
/ Sonisof
oligodendrocyte
Figure 1.5 - Oligodendrocyte.
Schwann cells are the counterparts to oligodendrocytes in the peripheral nervous
system. A single schwann cell can myelinate a short segment of a single axon.
Ependymal cells line the central canal of the spinal cord and the ventricles of the
brain and are responsible for the production of cerebrospinal fluid.
Microglia, on the other hand, are of mesodermal origin and play the role of
immune cells for the central nervous system. These cells are phagocytic and respond to
disturbances of the nervous system.
1.3 The Spinal Cord
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The spinal cord functions as the integral link between the brain and the peripheral
nervous system. It is protected by the spinal vertebrae (Figure 1.6A), meninges and
cerebrospinal fluid [5]. There are three meninges which surround the spinal cord. They
are the pia mater, arachnoid and the dura mater (Figure 1.6B). The dura mater is the
thickest of the three meninges.
A
Vertebral
body
Spinal
nerves
Pedicle
Spinal
Spinous Cord
process
B Dura mater
Pla mater
Arachnoid
mater subarachnoid
space
Figure 1.6 - (A) Cross-sectional view of the spinal
cord within the vertebra. (B) Illustration of the
spinal cord with surrounding meninges
The two distinct regions of the
spinal cord cross-section are the grey and
white matter (see Figure 1.7). The grey
matter is centrally located and has a
butterfly shape. It is composed primarily
of neuronal and glial cell bodies. The
dorsal horn of the gray matter is where the
dorsal roots are received. The ventral horn
of the gray matter is comprised primarily
of multipolar motor neurons the axons of
which form the ventral roots. The white
matter, on the other hand, is composed
primarily of descending and ascending
axonal tracts. Axons with common function,
origin and destination are found within
particular tracts (see Figure 1.7). The
central and peripheral nervous systems are
bridged by means of the dorsal and ventral
roots. The dorsal roots carry sensory signals
from the peripheral nervous system to the
central nervous system while the ventral roots
contain motor axons that relay motor
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commands from the central nervous system to the muscles through the peripheral nervous
system.
Dorsal roc
ganglion
Cell body of
sensory neuror
Dendrite of
sensory neuron
Reoeptor
-L
intemeuron Central canal
Dorsal root Synaose Dorsai comnn
Coticospina$ ~tract
Ratrospinal
tract
-spnothotaml
treaot
White matter
Grey mater
Cell body of motor teuron
7-
Venrral root
Axon of motor neuron
Synoptlo knobs
Fffector muscle
Figure 1.7 - The spinal cord cross-section showing the gray and white matter, dorsal and ventral roots,
various axonal tracts and a synapse for a spinal cord mediated reflex.
Some sensory inputs to the peripheral nervous system are responded to via spinal
cord mediated reflexes. This means that a sensory input (such as a pin prick) could be
responded to (i.e. muscle contraction) without the signal being relayed to the brain. This
is illustrated in Figure 1.7 by the synapse and interneuron connected within the gray
matter.
Each segment of the spine has a corresponding pair of dorsal and ventral roots.
These roots innervate specific areas of the body. Dorsal and ventral roots stemming from
12
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a specific segment of the spine generally innervate areas of the body at the same level as
the particular spinal segment. This is illustrated in Figure 1.8.
:C: Cervical
es Vertebrae
LATER4AL VIEW
Figure 1.8 - Areas on the human body and the corresponding spinal root locations for innervation.
The spinal cord is highly
vascularized. It receives blood supply
from one anterior and two posterior spinal
arteries. These arteries run longitudinally
throughout the length of the spinal cord.
Venous drainage of the cord is carried out
by three anterior and three posterior spinal
veins (Figure 1.9).
1.4 Normal Injury Response of the
Peripheral Nervous System
When an axon in the peripheral
nervous system is injured, degeneration
occurs both proximal (closer to the cell
Spinal arteries
(red)
Spinal veins
(blue)
Figure 1.9 - Vasculature of the spinal cord
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nucleus) and distal to the injury location. Initially, there is an influx of sodium and
calcium at the injury site and a significant loss of potassium and protein. The proximal
degeneration generally occurs only over a short distance. Axonal sprouting from the
proximal stump begins within a short time but axonal debris and scaring may fill the
defect and prevent proximal growth cones from reaching the distal stump. Distal
degeneration is characterized by Wallerian degeneration. The axon begins to degrade
while macrophages invade and remove remaining axonal debris from the Schwann cell
sheaths. Eventually, myelin sheaths begin to undergo disintegration and macrophages are
thought to be involved with the removal of the myelin debris as well. An endoneurial
tube is left along the entire length of the degenerated axon. If the injury gap is small
enough, an axon sprout may find a distal tube and continue to grow in length and
diameter until it eventually re-innervates its target while remaining sprouts from the
proximal axon stump degenerate. Neuroma may develop if the axon sprouts do not find
the distal tubular pathways. Also, if a sensory axon finds a distal tubular pathway of a
motor neuron or vice versa, the axon will not be functional [4]. Figure 1.10 illustrates the
process of peripheral nerve regeneration.
I~ ~ orI
/V
74
______ - I
Figure 1.10 - (A) An uninjured neuron. (B) The axon is severed and Wallerian degeneration begins. (C)
Axonal sprouting occurs from the proximal stump. Macrophages remove debris. (D) Axon begins
regenerating. (E) Regenerating axon finds target.
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1.5 Normal Injury Response of the Spinal Cord
Injury to the spinal cord results in two distinct modes of tissue damage. The first
is acute tissue damage which results directly form the disruption of the tissue and causes
extensive cell death at the injury site. The second mode of tissue damage, or secondary
tissue damage, is tissue degeneration that continues well after the initial injury.
Secondary damage occurs as a result of various events which occur is response to the
acute injury. Immediately following the initial injury, there is considerable hemorrhaging
that takes place and affects the normal oxygen and nutrient supply to the affected tissue.
The body then responds to the acute injury with a strong inflammatory response which
leads to edema of the spinal tissue. As this occurs, neural cells begin to die and release
excitotoxins such as glutamate which causes further neural cell death [6]. Another
adverse occurrence is the formation of free radicals which cause extended damage to
surrounding nervous tissue. The unfavorable conditions are heightened by the
demyelization of remaining axons due to the loss of oligodendrocytes. As spinal tissue is
lost and removed by phagocytes, fluid-filled cysts are formed within the lesion. Dense
fibrous and glial scar formation occurs at the injury site which impedes any attempts of
the axons to spontaneously regenerate across the defect. Reactive astrocytes, which form
the glial scar, express chondroitin sulphate proteoglycans, which inhibit axonal growth.
Other inhibitory molecules are found in the degenerating myelin including NOGO-A,
MAG, and OMpg [7]. In response to being severed, the distal segments of damaged
axons undergo Wallerian degeneration while the proximal segments retract away from
the injury site.
The rather hostile environment ensuing injury to the spinal cord impedes the
spontaneous regenerative processes, including axonal sprouting, that occur following
nerve damage.
1.6 Current Clinical Treatments of SCI and Ongoing Research
The emphasis of the initial treatment of a spinal injury is on immobilization of the
spinal column to prevent further nerve damage. Surgical intervention is commonly
required to provide realignment and stabilization of the spine and decompression of the
spinal cord. The intravenous administration of methylprednisolone in high dosages
15
within 8 hours of injury was reported by Bracken et al. to significantly reduce the effect
of secondary injury in a multicenter randomized clinical trial. Methylprednisolone was
reported to be of benefit only if administered within the 8 hour period following spinal
cord injury [8]. Despite the broad acceptance of methylprednisolone as a clinical
treatment for SCI there is still considerable controversy over the efficacy of this steroid
treatment [9]. To date there are no clinical therapies which actively promote the
regeneration of the damaged nervous tissue.
Many experimental SCI treatment strategies are being investigated in animal
models and reported in the literature with varying degrees of promise. Some approaches
to spinal cord regeneration involve development and evaluation of various substrates to
provide guidance and act as a bridge to axonal growth across a defect in the spinal cord
[10-12]. The focus of some studies is the ability of certain neurotrophic factors and gene
therapy strategies for creating favorable conditions for axonal growth. Other studies have
looked at the implantation of various cell types into the damaged spinal cord to replace
lost cells and facilitate nerve repair [14]. Various stem cell approaches have been
studied, including the implantation of neural stem and progenitor cells into spinal cord
lesions [15]. In many studies the implanted cells are first genetically encoded to express
specific neurotrophic factors [16]. Bone marrow mesenchymal stem cells implanted into
damaged spinal cords of adult rats have been reported to simulate nerve regeneration [17-
20]. Lu et al. reported that BDNF-expressing marrow stromal cells supported axonal
regeneration in adult rats [21]. Furthermore, olfactory ensheathing glia have been
reported to promote long distance axonal growth when implanted into the defect of a
transected rat spinal cord [22-24]. In another study, neurotrophin-3 (NT-3) expressing
olfactory ensheathing glia cells were reported to promote spinal sparing and regeneration
in adult rats [25]. While some researchers only implant cells into the spinal cord lesion
others implant them in combination with a biomaterial scaffold [26-28]. The
identification of inhibitors to regeneration (such as NOGO-A) and the application of
agents to block or overcome these inhibitors has shown promise in improving axon
recovery after spinal cord injury [7, 29-31]. In one study, the use of an oscillating field
stimulator, which produced an electric field across a lesion in the spinal cord, was shown
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to induce limited sensory recovery and improve motor function in patients participating
in a phase 1 clinical trial [32].
Previous work in our laboratory has shown the effectiveness of collagen tubes in
promoting axonal regeneration across significant gaps in the rat peripheral nerve [33, 34].
The tubes performed better than the nerve autograft "gold standard". Our laboratory has
also investigated the use of collagen tubes for spinal cord regeneration. Results showed
that tubulation of a transected adult rat spinal cord had beneficial effects on spinal cord
healing such as a reduction in scar formation and improved axonal and connective tissue
orientation within the defect [35, 36]. This past work forms the basis for the current
hypothesis that collagen based implants have beneficial effects on spinal cord
regeneration.
Notwithstanding the encouraging results for spinal cord regeneration that many
researchers have reported in the literature, there has yet to be a single therapy which can
provide satisfactory recovery from traumatic spinal cord injury. It is likely that an
effective treatment for spinal cord injury will require a multifaceted approach to nerve
regeneration; combining various spinal cord regeneration strategies.
1.7 Aim of Research Project and Specific Goals of this Thesis
The long term objective of this research project is the development of an implant
for the treatment of spinal cord injuries in humans. The implant will likely make use of a
combination of therapies shown to support regeneration of the spinal cord. The therapies
currently investigated include porous, structurally aligned, bioresorbable collagen
scaffolds, stem cell therapies, inhibitor blocking antibodies, and the use of neurotrophic
factors delivered via scaffold binding and/or cellular transfection.
The specific aim of this thesis is to compare select collagen implants for their
abilities to promote axon regeneration in the adult rat spinal cord. The goal is to find an
optimal entubulation strategy which can be used in the future in combination with the
spinal cord regeneration therapies mention above. The primary method for the evaluation
of the efficacy of the various implants will be qualitative histology and quantitative
axonal regeneration analysis.
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The BioGide@ sheets were prepared into a slurry suspension (5% w/w) by cutting
them into small pieces (1 mm 2) then mixing with a 0.5 M acetic acid solution. The
collagen slurry was thoroughly mixed until a homogenous mixture was achieved. A 10-
ml syringe containing the collagen slurry was attached to another 10-ml syringe with a
Luer-lock assembly, and mixed by injecting collagen slurry from one syringe into the
other (approximately 30-40 times) until the collagen fibers began to hydrate and the
solution appeared uniform.
After letting the slurry sit for 3 hours at room temperature to allow for the
collagen fibers to swell, the collagen slurry was centrifuged in order to de-gas the
collagen so that any macroscopic air bubbles were removed from the slurry.
During centrifugation the slurry tended to separate into two phases. In order to
re-homogenize the slurry, it was gently mixed using the syringes and Luer-lock assembly
2-3 times very slowly taking care not to allow any air to be mixed into the solution.
The collagen slurry was injected into the Teflon mold. The slurry (~0.8 ml per
tube) was injected into one side of a channel in the closed mold until it started to come
out of the other side of the channel. The glass rod with its silicone sheath was then
inserted into the channel which had been filled with slurry. The rod was rotated during
its insertion so as to keep the rod centered in the channel and to maintain a uniform
coverage of the rod with the collagen slurry throughout the channel. When the rod came
out of the other side of the channel, a centering ring/spacer was slipped over the rod.
This procedure was repeated for each of the 6 channels in the mold.
The mold was placed into a freeze-drier (set to -40'C) for 1 hour. After freezing,
the mold was removed from the freeze-drier and quickly split open, in order for the
frozen collagen tube to be gently removed from the mold. The glass/silicone rods were
kept inside of the collagen tubes. The tubes with the rods in place were inserted back into
the freeze-drier (at -40 0C).
A vacuum below 100 mTorr (taking ~30-60 minutes to reach) was applied to the
freeze-drier. The temperature was then raised to 0*C and the samples left overnight
under vacuum in the freeze-drier (17 hours). The temperature was subsequently raised to
20'C and the vacuum released.
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implant a device for facilitating axonal regeneration. Unilateral hemesectional models
offer the advantage of being able to assess an implanted device while still preserving the
structural integrity and function of one side of the spinal cord [26].
For this study the complete transection model was chosen as it offers the best
method for evaluating the effects of an implanted device on axonal regeneration.
2.3 Animal Model
The most common animal model used for spinal cord injury research is the adult
rat. For this reason there is an abundance of data in the literature that allows for easy
comparison of result from different studies. Compared to other animals, rats are
inexpensive, can be studied in large numbers, require less intensive post operative care,
and have relatively low mortality rates. Transgenic mice offer the researcher the
distinctive ability to control particular genetic characteristics; however, the small size of
mice may prohibit certain surgical procedures and device implantations [37].
Larger animal models such as cats, dogs, pigs and primates are not used as widely
in the literature. These animal models are less attractive due to the higher cost and more
intensive animal care; however, using a large animal model may be important before
performing trials on humans.
In this study, the rat was chosen as the animal model for the reasons mention
above and also due to the fact that our laboratory has extensive experience in using rats
for both peripheral nerve and spinal cord regeneration studies [13, 33-36, 39, 40].
Female rats were used in this study because they allow for easier management of
the loss of reflex bladder control following spinal cord transection. The loss of bladder
function necessitates the manual expression of urine from the bladders of the rats
following complete spinal cord transection. Using female rats facilitates the manual
expression of the bladder.
2.4 Rat Strain Choice
The first three experimental groups in this study used Sprague-Dawley (SD) rats
weighing between 250 to 300 grams. There was an approximately 40% incidence of self-
mutilation in the SD rats, most commonly in the form of extreme biting of the skin of the
23
Chapter 2: Methods and Materials
2.1 Collagen implants
The collagen implants used include a collagen tube and a collagen sheet.
2.1.1 Tube Fabrication Materials
Collagen tubes were fabricated from a slurry prepared from BioGide® sheets
composed of types /111 collagen. The protocol used is a modification of the method
previously used for making tubes in our laboratory from bovine collagen and reported in
the literature [13].
A mold was used to form the collagen tubes out of the collagen slurry.
Polytetrafluoroethylene (Teflon) was used to make the mold, which contained six
channels, each 5 mm in diameter, drilled through the Teflon. The Teflon mold is
contained within an aluminum housing to provide rigidity (see Figures 2.1 and 2.2).
WLSTCOrTT
n housing
5-mm diameter channel in the
Teflon mold: there are 6 channels
Figure 2.1 - Mold used for fabricating collagen tubes.
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The collagen tubes (with the glass/Teflon rods in place) were removed from the
freeze-drier and placed into aluminum foil bags for storage.
Collagen tubes were dehydrothermally crosslinked flowing the freeze-drying
process. The tubes were placed in a vacuum oven for 24 hours at 1050 C. This step also
served the purpose of sterilization of the tubes. The detailed protocol for dehydrothermal
treatment is in Appendix A.
The tubes fabricated using the above technique had the following dimensions:
inner diameter of 2.95-3.0 mm and outer diameter of 4.7-4.8 mm. A picture of a tube is
shown in Figure 2.4.
Figure 24 - Collagen tube (scale is mm).
2.1.2 BioGide@ Membrane
The BioGide® (Geistlich Biomaterials, Wolhusen, Switzerland) sheet is a
collagen type I/III membrane that is commercially available in the US and in many
European countries. Its primary use is in certain dental and maxillofacial procedures.
The membrane has a bilayer design which combines 2 distinct layers to form the
membrane. One is a smooth dense layer which is less permeable while the second is a
porous layer which favors tissue integration. Figure 2.5 shows the microstructure of the
BioGide@ membrane (taken from the Geistlich Biomaterials website).
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View of the smooth, compact side
(SE M 1500 x)
K:t- t
view of the rough, porous side
(SEM 1500 x)
Figure 2.5 - Illustration of the microstructure of the BioGide@ membrane.
2.2 Spinal Cord Injury Model
There are a wide variety of injury models that are used in spinal cord injury
research. Contusion and compression models are often chosen as they more closely
parallel SCI seen in the clinic. These models may be better suited for studies which
investigate treatments designed to manage the onset of secondary tissue damage [37].
Experimental contusion injuries are often created by using a computer controlled
impactor or a weight drop device which drops a weight on the exposed spinal cord [18,
19, 38]. Experimental compression injuries are often created by applying a surgical
spring-loaded clip or a balloon which applies pressure on the spinal cord. Complete
transection models fully sever the spinal cord. This approach has the advantage of being
able to unambiguously demonstrate the regeneration of axons into the lesion; something
that would be difficult with a contusion model since it is not easy to distinguish between
spared and regenerated axons. Another advantage of a transection model is the ability to
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Closed Mold: Side View
Groo b 1G rov
Teflon Aluminum
000.
Figure 2.2 - Side view of closed mold.
Glass rods were used to form the lumen of the tubes and were contained within a
silicone sheath. Each glass rod was 2.5 mm in diameter (measured 2.46-2.48 mm). The
silicone tubing fitted over the glass rod had an inside diameter of 2.5 mm and an outside
diameter of 3.0 mm.
In order to center the rod in the middle of the channel, a Teflon spacer was
inserted over the end of the rod as it came out either end of the channel (i.e., 2 Teflon
spacers per rod). The Teflon spacers have an inside diameter of 3.0 mm and an outside
diameter of 5 mm. The nominal inner diameter of a tube prepared in the mold was 3 mm;
the outer diameter was 5 mm. Figure 2.3 shows the glass rod with a silicone sheath and
Teflon spacers.
Figure 2.3 - View of the glass rod with a silicone sheath and Teflon spacers in the open mold.
2.1.2 Tube Fabrication Protocol
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abdomen. In many cases, the self-mutilating animals had to be euthanized due to the
severity of the lesions. This prompted the investigation of the use of an alternative rat
strain. In the literature it is reported that Lewis rats alone do not exhibit self-mutilation
following sciatic nerve injury [41, 42]. However, there has been no clear comparison for
spinal cord work. Because of the notable difference in the rates of self-mutilation of
Lewis rats compared to other rat strains for peripheral nerve injuries, it was hypothesized
that a similar reduction in incidence of self-mutilation would be seen for spinal cord
injuries. One disadvantage of the Lewis rat is its smaller size which increases the
difficulty of the surgical implantation. Adult Lewis rats are about 40% smaller than adult
SD rats. Notwithstanding this drawback, a switch to using Lewis rats was made in order
to reduce the rates of self-mutilation. In our experience to date with the Lewis rats, we
have not had any cases of self-mutilation.
2.5 Rat Surgery
Adult female Sprague Dawley (groups I-III) or Lewis rats (group IV) (Taconic,
Germantown, NY) weighing 250-300 and 150-175 grams respectively were used in this
study. All animal care and surgical procedures were performed at the Veterans
Administration Medical Center Animal Research Facility (Jamaica Plain, MA). All
surgical and post-operative procedures were approved by the VA Boston Healthcare
System Institutional Animal Care and Use Committee (IACUC).
Rats were anesthetized by an intraperitoneal injection with sodium pentobarbital
(Nembutal solution, 50 mg/ml, Abbott Laboratories, North Chicago, IL) at a dosage of 45
mg/kg. The hair on the back of the anesthetized rat was shaved and the
skin was cleaned with Betadine. Surgery was performed under sterile conditions. A
continuous oxygen supply was supplied to the rat during surgery. The rat was placed on
a flat operating board in a prone position and the rat's limbs were gently constrained with
rubber bands in an extended position. A longitudinal incision, 2 inches in length, was
made through the skin above the thoracic spine. The back musculature was incised along
the midline and dissected away from the vertebral column. A dorsal laminectomy was
performed between T7 and TlO using small bone rongeurs and microscissors. The dura
was opened with a surgical blade to expose about 10 mm of spinal cord (Figure 2.6 -
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left). Two spinal cord segments (T8 and T9) were removed by performing two complete
transections and removing the intervening tissue. This resulted in a 5 mm long gap in the
spinal cord (Figure 2.6- right). The nearest pair of spinal roots entering the intact rostral
(T7) and caudal (T10) spinal cord was severed. Gelfoam was temporarily placed in the
gap to induce hemostasis.
Figure 2.6 - Left: 10 mm section of exposed spinal cord. Right: 5 mm gap created in thoracic spinal cord
This thesis will report on 4 experimental groups. Group I (n = 8) is a control group. The
animals in this group had a complete spinal cord transection as described above but
received no implantation (Figure 2.7A). Group II (n = 7) received a resorbable dura
replacement sheet of collagen, 1 mm thick, cut from the BioGide@ membrane which was
placed extradurally over the dorsal aspect of the wound site and extended 2 mm past the
spinal cord stumps on both sides of the defect (Figure 2.7B). Group III (n = 4) used the
BioGide@ membrane as a wrap which bridged the two stumps by tucking the BioGide®
membrane under the stumps then folding the sides of the sheet over the top of the defect
to enclose the gap (Figure 2.7C). Group IV (n =7) used the collagen tube, which was
split open with a single cut along the long axis of the tube immediately prior to
implantation, allowing for easier insertion of the ends of the cord into the tube (Figure
2.7D). After the stumps of the cord were inserted into the tube the tube automatically
recovered its original shape, bringing the split ends together. As a result, sutures were
not necessary to keep the tube closed. All implants were briefly hydrated in sterile saline
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prior to implantation. Tubular implants were carefully filled with sterile saline to remove
air bubbles within the tubes.
Level of the bone on the sides of the spinal cord
I
A
B
C
D
Figure 2.7 - (A) Group I: Control, no implantation. (B) Group H: BioGide@ collagen membrane used as adorsal barrier. (C) Group III: BioGide@ collagen membrane used as a wrap. (D) Group IV: Collagen tube
spilt longitudinally and tucked under spinal cord stumps.
26
BFne
I Bone [
Figure 2.8 - (A-C) The wrapping of the spinal cord stumps using the collagen membrane for Group II
animals. (D-F) The bridging of the spinal cord stumps using the collagen tube for Group IV animals.
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Figure 2.9 - The collagen membrane placed over the defect area for Group II animals.
Following placement of the respective implants, the overlying musculature was
closed with 4-0 vicryl sutures (Johnson and Johnson, Sommerville, NJ) and the skin was
closed with wound clips.
Immediate post operative care of the animals included placement of the rat on a
heating pad to maintain body temperature, subcutaneous injection of 1-2 ml of lactated
Ringer's solution to compensate for blood loss during surgery, subcutaneous injection of
antibiotics (cefazolin sodium 100 mg, Abbot Laboratories, North Chicago, IL), and a
continuous supply of oxygen until the animal regained consciousness 4-6 hours later
(Figure 2.10). After regaining consciousness, the rats were transferred to plastic cages
with fresh wood chip bedding and free
access to food and water. An analgesic,
buprunorphine (Buprenex 0.3 mg/ml), was
administered every 12 hours for 4 days
following surgery by intramuscular injection
into a hind leg of the animal at a dosage of
0.1 ml and 0.06 ml for the SD and Lewis
rats respectively. Subcutaneous injection of
lactated Ringer's solution (2 ml per day) was
Figure 2.10 - Rat post-operative care.continued for 4 days following surgery to
prevent dehydration. Administration of antibiotics (cefazolin sodium) was continued for
2 weeks, to prevent bladder infection, at a dosage of 0.15 ml and 0.09 ml per day for SD
and Lewis rats respectively. Post-operatively, animals lacked normal micturition reflex
28
and their bladders had to be emptied manually every 12 hours using Crede's maneuver.
The SD rats recovered spontaneous voiding ability after 2-3 weeks at which point manual
bladder expression was stopped; however, the Lewis rats did not recover spontaneous
voiding ability during the length of this study (6 weeks).
2.6 Spinal Tissue Removal
Six weeks post surgery the rats were sacrificed by carbon dioxide inhalation.
Immediately following sacrifice, the skin covering the spinal column was incised and the
site of spinal cord injury was located. The thoracic spinal column was removed using a
scalpel and surgical scissors. The steps are shown in Figure 2.11. The extracted spine
was placed in 10% buffered formalin at 4*C for a minimum of 72 hours.
Figure 2.11 - Steps for the extraction of the thoracic spinal column.
The intact spinal cord (2.12), including the defect area, was removed from the extracted
vertebral column using bone ronguers and fine surgical scissors. The defect could be
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located during the spinal cord extraction process due to the absence of the dorsal aspects
of the T7 through T10 vertebrae which underwent laminectomy during the spinal surgery.
The extracted spinal cord was then cut at the center of the defect using a No.11 surgical
blade creating two spinal cord segments; one rostral to the defect-center and one caudal
to the defect-center.
Rostral _- I
nEpon
Caudal
Figure 2.12 - Top: Image of extracted spinal cord (scale marks are mm). Black bars indicate location of
lesion. Bottom: Illustration of the sections of the extracted spinal cord to be embedded in Paraffin (wax)
and Epon (plastic).
2.7 Histology
2.7.1 Plastic Embedded Specimen
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The spinal cord segment rostral to the defect-center was embedded in epon
(plastic) using a Poly/Bed 812 Embedding Kit (Catalog No. 08792, Polysciences, Inc.,
Warrington, PA). The detailed embedding protocol is shown in Appendix B. Prior to
embedding the specimen was post-fixed in 1% osmium tetroxide to stain for myelin.
Plastic embedded specimens were mounted onto an ultramicrotome and 1 pIm thick
sections were cut to capture the cross-
sectional area of the defect-center.
Plastic sections containing spinal tissue
were stained with toluidine blue, to
provide better contrast for light
microscopy analysis, and then mounted
on glass slides and coverslipped. Figure
2.13 shows a plastic embedded
specimen.
Figure 2.13 - Image of plastic embedded spinal
cord section2.7.2 Wax Embedded Specimen
The spinal cord segment caudal to the defect-center was embedded in paraffin
using a tissue processor (HypercenterXP, Tissue Processor, ThermoShandon, Houston,
TX). Longitudinal sections of the defect were cut at 6 gim with a microtome, mounted on
glass slides and coverslipped.
Adjacent tissue sections were stained with hematoxylin and eosin (H & E) for
general observation of cellular and extracellular matrix features and Masson's trichrome
which was used to identify the presence of collagenous tissue within the defect. The
protocols used for these staining methods are listed in Appendix C.
2.7.3 Method for the Quantitative Analysis of Axonal Regeneration
Plastic embedded cross-sections of the defect-center which were stained with
osmium tetroxide and toluidine blue were examined using a light microscope outfitted
with a digital camera. Images of the defect-center were captured first at low
magnification (40x) in order to view the entire lesion cross-section (Figure 2.14A).
Additional images were captured at 200x magnification to provide sufficient resolution
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for the identification of individual axons (Figure 2.14B). The images were opened in
Adobe Photoshop and were converted to black and white; then the brightness and
contrast were increased until the axons were clearly outlined (Figure 2.14C).
The black and white images were analyzed using ImageJ software (available as
freeware from NIH, Bethesda, MD). This software can be utilized to measure various
parameters in the histological section including: the total number of axons, the area of
each individual axon, the average axonal area and standard deviation, the percentage of
the cross-sectional area of the spinal cord covered by axons, and the major and minor
axes of elliptical approximations of axons with non-circular cross-sections. Figure 2.14D
shows the outlines and numbering of each axon, that were produced using ImageJ.
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Figure 2.14 - (A) Cross-section of the center of the lesion of a control animal (no implantation) (40x). (B)
200x magnification of the lesion center. (C) High contrast black and white image of spinal cord section.(D) Numerical labeling and outlining of individual axons.
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Chapter 3: Results
3.1 Survival Post-Surgery
A total of 36 rats (28 Sprague Dawley (SD) and 8 Lewis) underwent surgery.
Only 1 SD and 1 Lewis rat died during the operation; however a total of 11 SD rats died
post-operatively. In general, the rats that did not survive, died within a few days after
surgery. A couple animals died after a few weeks due to bladder infection. Eleven SD
rats exhibited self-mutilation; 3 of which were euthanized due to the mutilation. None of
the Lewis rats died post-operatively and none exhibited self-mutilation. The number of
rats from each experimental group which survived for six weeks after surgery is show in
Table 3.1.
Table 3.1 - Experimental Groups
Group: Implant Type Number of Rats
Group I: Control (no implant) 8 (SD)
Group II: Collagen membrane used as dorsal barrier 7 (SD)
Group III: Collagen membrane used as a wrap 4 (SD)
Group IV: Collagen tube spilt longitudinally (opening of tube on 7 (Lewis)
dorsal side of spinal cord)
. All the rats exhibited complete hindlimb paralysis following surgery and moved about
their cages by exclusive use of their forelimbs.
3.2 Functional Ability
Digital video recording of rat ambulation was taken for all animals at 6 weeks
post operatively. Although no formal grading system was used to assess motor function;
no discernable differences in functional recovery were noticeable among the four
experimental groups based on our general observations. Animals from all groups showed
slight uncoordinated hind limb motion without significant weight bearing ability. Figure
3.1 (top) shows three consecutive snapshots taken 0.5 seconds apart of a video recording
of a tube implanted rat. Figure 3.1 (bottom) shows three consecutive snapshots taken 0.5
seconds apart of a video recording of a normal Lewis rat (no spinal cord injury).
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Figure 3.1 - Three consecutive snapshots (left to right) taken 0.5 seconds apart of a tube implanted rat
(top) and a normal (no spinal cord injury) rat (bottom).
3.3 Morphological Observations
Six weeks after surgery, extraction of the rat spinal cords revealed reparative
tissue completely filling the 5 mm gap created by spinal cord transection in all of the
experimental groups. The tissue at the center of the defect in all animals lacked the
normal spinal cord anatomy, which is comprised of distinct areas of gray and white
matter. Images taken of the cross-sections of plastic embedded spinal cord defect areas
were analyzed using InageJ to determine defect-center cross-sectional areas and aspect
ratios. The cross-sectional areas of the center of the defect of the four experimental
groups are shown in Figure 3.2. The cross-sectional area of a normal SD adult rat spinal
cord was found to be approximately 4.5 mm 2; indicated by the dashed line in Figure 3.2.
Groups I, I, and IV had cross-sections slightly less than normal. The average cross-
sectional area in Group II was approximately the same as normal.
The aspect ratio is a measure of the circularity of the cross-section; where a
perfect circle has an aspect ratio of 1. In non-circular cross-sections, the aspect ratio is
the ratio of the major axis divided by the minor axis (i.e. long diameter/short diameter).
The aspect ratio of a normal adult SD rat spinal cord cross-section in the thoracic region
of the spine is approximately 1.1. A comparison of the average aspect ratios of the four
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experimental groups is shown in Figure 3.3. The group with the smallest aspect ratio (i.e.
most circular cross-section) was the tubular implant group (Group IV). The group with
the largest aspect ratio (and also the largest cross-sectional area) was Group II.
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Figure 3.2 - Graph comparing average cross-sectional areas of the lesion centers for the four experimental
groups. Dashed line indicates cross-sectional area of a normal rat
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Figure 3.3 - Graph comparing the aspect ratios of the lesion center cross-sections.
3.4 Histological Findings
Longitudinal sections were taken of the paraffin embedded spinal cord segment
rostral to the defect-center. These sections were stained with H & E for general cell
identification and Masson's Trichrome to identify the presence of collagenous tissue
(Figure 3.4). Transverse sections of the defect-
Defect Center center were stained with osmium tetroxide and
toluidine blue for axon quantification (Figure
3.4). The transverse sections were also used for
general morphological observations.
Longitudinal and transverse sections of a normal
Longitudinal Defect Center
Section Cross-Section (uninjured) thoracic level rat spinal cord are
Figure 3.4 - Sectioning strategy. shown in Figure 
3.5.
Longitudinal sections were stained with H&E H & E staining showed the presence of
or Masson's Trichrome. Defect center cross-
sections were stained with osmium tetroxide large cysts filling the defect areas of Groups I
and toluidine blue.
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and II, while groups III and IV
demonstrated less extensive cyst
formation (Figures 3.6-3.9). At the
interface between the rostral spinal cord
stump and the reparative tissue in the
gap there was a marked accumulation of
Figure 3.5 - Normal rat spinal cord. Longitudinal cells, possibly astrocytes and
section (left) stained with H&E. Transverse section
(right) stained with toluidine blue. macrophages, in all four groups. Acute
inflammatory cells (polymorphonuclear
neutrophils, basophils, and eosinophils) were not observed in any of the groups, which
indicates an absence of an immune response to the collagen implants. Masson's
trichrome showed a high degree of dense collagenous tissue within the defect of groups I
through IV, while H & E revealed fibroblasts with their characteristic elongated
morphology dispersed within the collagenous extracellular matrix. In Groups I and II the
orientation of the collagen fibers tended to be in a transverse direction (Figure 3.1 OA).
The collagen fibers in Group III tended to be more longitudinally oriented, and even
more so in Group IV (Figure 3.1OB).
After six weeks, the collagen implants in Groups II - IV underwent considerable
degradation; however, disintegrating portions of the collagen implants were visible in
Groups III and IV (wrap and tube). Remnants of the wrap were highly visible (Figure
3.8), even though considerable fragmentation of the wall of the wrap occurred, whereas
only small remains of the tube could be seen.
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Figure 3.6 - Explanted
spinal cord of control
animal showing a large
cyst (*) at the interface
between the defect and
undamaged cord.
Longitudinal section
(left) stained with
Masson's Trichrome.
Transverse section of
defect center (right)
stained with toluidine
blue.
Figure 3.7 - Explanted
spinal cord of Group II
rat showing numerous
cysts (*) filling the
defect. Longitudinal
section (left) stained with
Masson's Trichrome.
Transverse section of
defect center (right)
stained with toluidine
blue.
Figure 3.8 - Explanted
spinal cord of Group II
(wrap) rat showing
improved integration of
tissue within the defect and
adjacent undamaged spinal
cord. Remains of the
collagen wrap are clearly
visible in transverse section
(arrows). Long. section
(left) stained with
Masson's Trich. Trans.
section (right) stained with
toluidine blue.
Figure 3.9 - Explanted
spinal cord of Group IV
(tube) rat demonstrating
fewer cysts within the
defect. Longitudinal
section (left) stained with
Masson's Trichrome.
Transverse section of
defect center (right)
stained with toluidine
blue.
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Figure 3.10 - High magnification of the defect center showing a highly collagenous tissue composition. (A)
The group with only the dorsal barrier implanted showed the collagenous tissue within the gap orientated
transverse to the spinal cord axis (arrows). (B) The group with the tubular implant showed the tissue within thedefect to be closely aligned with the spinal cord axis. Paraffin embedded sections were stained with Masson's
trichrome which stains collagen blue, cellular material red, and cell nuclei purple.
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3.5 Axonal quantification
Myelinated axons at the center of the defect were identified by post-fixing the
caudal segments of the spinal cord explants in 1% osmium tetroxide to stain for myelin.
Toluidine blue staining of the sections was also done, to provide better contrast of the
tissue. High resolution images (200x) taken under light microscopy were used to observe
myelinated axons, which were found in all four experimental groups. In groups I and II
regenerated axons were often found in high density bundles, or fascicles on the periphery
of the defect cross-section (see Figures 3.11 and 3.12). In contrast, the axons in groups
III and IV were not found in fascicles, but were generally spread across the cross-
sectional area (see Figure 3.13 and 3.14).
Figure 3.11 - Left: The cross-section of the defect-center of a control animal (scale bar = 200 pm). Right:
a high magnification image of myelinated axons found within a large fascicle on the periphery of the cross-
section (scale bar =20 pm).
Figure 3.12 - Left: The cross-section of the defect-center of a dorsal barrier implanted animal (scale bar =
200 pm). Right: a high magnification image of myelinated axons found within a large fascicle on the
periphery of the cross-section (scale bar = 20 pm).
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Figure 3.13 - Left: The cross-section of the defect-center of a wrap implanted animal (Group II) (scale bar
= 200 pm). Axons in this group were not found in large fascicles but were generally spread across various
areas of the defect. Right: a high magnification image of myelinated axons found in the central region of
the defect (scale bar =20 pm).
Figure 3.14 - Left: The cross-section of the defect-center of a tube implanted animal (Group IV) (scale bar
= 200 pm). Axons in this group were not found in large fascicles but were generally spread across various
areas of the defect. Right: a high magnification image of myelinated axons found in the central region of
the defect (scale bar = 20 pm).
The total number of axons found at the defect-center in each group is shown in
Figure 3.15; the error bars indicate standard deviation. Interestingly, the number of axons
found was similar among the three implant groups and the control group; ranging
between 1000 and 1700 axons. A one-way Analysis of Variance (ANOVA) test showed
no statistical significance between the mean values of each group (P > 0.05). In
comparison, the number of axons in the thoracic region of a normal rat (without spinal
cord injury) was found to be approximately 130,000.
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Figure 3.15- Graph showing the mean number of axons found
Group4
at the lesion center.
Analysis of the aspect ratios of the axons found within the gap showed that all the
groups had mean aspect ratios near 2 (P > 0.05). The aspect ratios were 2.04 ± 0.25
(mean + SD, n=8), 1.83 ± 0.17 (n=7), 2.13 ± 0.336 (n=4) and 1.98 ± 0.25 (n=7) for
groups I through IV respectively.
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Chapter 4: Discussion
The objective of this study was to investigate the effects that collagen implants
have on the regeneration of the adult rat spinal cord. Three implants were evaluated
including a thin collagen membrane used as a dorsal barrier to overlaying soft tissue
covering a 5 mm gap in the spinal cord, the same collagen membrane used as a wrap to
enclose the ends of the cord stumps, and lastly a collagen tube that was opened
longitudinally and used as a bridge between the two cord stumps.
Each of the evaluated implants provided containment of the defect by preventing
the invasion of surrounding tissue into the spinal cord gap. Invading tissue acts as a
barrier to axons trying to cross the lesion. Tubular shaped implants provided a unique
enclosure which could be beneficial for controlling the environment of the lesion.
Histological analysis showed a large amount of collagenous tissue filling the
defect gap of all animals 6 weeks after surgery. The control group and dorsal barrier
implanted group showed significant numbers of large fluid-filled cysts within the defect;
whereas cysts were largely absent from the wrap and tube implanted groups. There were
also notable differences in the orientation of the scar tissue within the gaps of tubular and
non-tubular groups. The scar tissue in the tubular groups tended to be considerably inline
with the axis of the spinal cord; whereas the control and dorsal barrier groups had scar
tissue oriented transverse to the spinal cord axis. These findings are consistent with the
results published by Spilker et al. who found a similar difference in scar orientation
between tubular and non-tubular implanted animals [35].
The complete transection model (and removal of nearby peripheral nerve roots)
ensures that all ascending and descending axons are disrupted. Therefore, any axons
found at the defect-center can be assumed to be regenerated axons. Images taken at high
magnification of myelin stained cross-sections of the defect, revealed distinctive patterns
of regenerated axons at the defect-center of the different groups. In the control and dorsal
barrier groups, a large number of the regenerating axons were found in large fascicles on
the periphery of the cross-section. This was in stark contrast to the pattern seen in the
wrap and tube groups, where the regenerated axons were found spread across different
areas of the defect cross-section. It was not possible to determine the origin of the
regenerated axons and it is likely that some, if not many, of the axons were ascending
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tract axons originating in the peripheral nervous system. This is consistent with the
identification of well defined fascicules in groups I and II on the periphery of the defect
cross-section. The tubular implant groups are less likely to support the in-growth of
peripheral nerve originating axons due to the tubular construct acting as a wall to the
adjacent severed peripheral nerve roots.
The quantification of myelinated axons found at the defect-center revealed a
notable number of regenerated axons penetrating the defect in all of the experimental
groups. The differences among the total number of regenerated axons in each group was
not significant. Similarly, there was little difference in the mean aspect ratios of the
regenerated axons from each group; with the mean aspect ratio being approximately 2 in
all groups. These results concur to some extent with those published by Spilker et al.
[35] who found no significant difference in the number of regenerated axons in tubular
and non-tubular implanted groups; however, Spilker et al. reported differences in the
aspect ratios of the axons in tubular and non-tubular groups.
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Chapter 5: Conclusion
Damage to the spinal cord results in an extremely hostile environment for axonal
regeneration. Notwithstanding, tubular shaped collagen based implants help counter
adverse conditions within the defect by reducing the formation of large fluid-filled cysts
and providing more favorable organization of the scar tissue by aligning the tissue closely
with the axis of the spinal cord. The tubular implants were supportive of axonal
regeneration within the defect, and the number of regenerated axons found within all of
the groups is encouraging.
Even so, it is clear that a multifaceted approach is necessary to effectively
facilitate satisfactory regeneration of the spinal cord. This may include the use of stem
cells, growth factors, and a porous cylindrical scaffold. The collagen implants
investigated in the current study (i.e. dorsal barrier and/or tubular implants) could provide
a working platform for the incorporation of these additional therapies.
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Appendix A: Dehydrothermal Crosslinking Protocol (adapted from Harley, 2002)
1. Place collagen material in aluminum foil packet. Leave packet open at top.
2. Place packet in vacuum oven (Isotemp Model 201, Fisher Scientific, Boston,
MA).
3. Turn on vacuum. The vacuum oven should reach a final pressure of
approximately 29.7 mmHg. Leave the matrix in the oven for 24 hours at 105C.
4. At the end of the exposure period, turn off the vacuum and vent the chamber.
Open the vacuum door and immediately seal the aluminum foil bags. The matrix
is now crosslinked and considered sterile, so the matrix should only be handled
under sterile conditions from now on.
5. Store the matrix in a dessicator. Crosslinked matrices can remain indefinitely in a
dessicator prior to testing or use.
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Appendix B: Plastic Embedding Protocol
SOLUTIONS:
Cacodvlate Buffer (nH 7.4)
Stock Solutions:
Stock A: 0.2 MSodium Cacodylate in liquid form (pH 7.4)
(Catalog No. 18661, Polysciences, Inc., Warrington, PA)
Final Molar Composition of Buffer (Working Solution):
50 ml of Stock A + 50 ml of Distilled Water
Gives 0.1 M Sodium Cacodylate (pH 7.4)
OR
Stock A (0.2 M Sodium Cacodylate - mw 214): 4.28 grams Sodium Cacodylate
(powder)
100 ml of Distilled Water
Stock B (0.2 M HCI - mw 36.46): 1.7 ml HCl
100 ml of Distilled Water
* = Volume of Stock B changes for different pH levels
Composition of Buffer:
50 ml of Stock A + 1.4 ml of Stock B (for pH 7.4)* + 48.6 ml Distilled Water
* = Volume of Stock B changes for different pH levels
Final Molar Composition of Buffer:
0. 1M Sodium Cacodylate
0.0028M HCl
Cacodylate Buffered
2% Solution:
Glutaraldehyde
8 ml 25% Glutaraldehyde
92 ml working cacodylate Buffer
Osmium Tetroxide Solution (Catalog No. 251755, Sigma-Aldrich, St. Louis,MO)
1% Solution: 2 ml 4% Osmium Tetroxide
6 ml working cacodylate buffer
Note: Can use 1-2% Osmium Tetroxide in 0.1M buffer
Poly/Bed 812 Embedding Kit (Catalog No. 08792, Polysciences, Inc., Warrington, PA)
Half Portion:
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Catalog # I Standard Formula Slightly HarderI
Poly/Bed 812 08791 24 ml 23.5 ml
DDSA 00563 15.5 ml 14.3 ml
NMA 00886 10.5 ml 12.0 ml
DMP-30* 00553 1.0 ml 1.0 ml
EMBEDDING PROCEDURE
1. Soak nerves in 2% cacodylate buffered glutaraldehyde 2-4 hours at 4'C (or on ice).
2. Rinse nerves 3 times in 0.1 M working cacodylate buffered solution, 5 min each.
3. Fix in 1-2% osmium tetroxide solution for 1-2 hours at room temperature (in the hood)
in dark.
4. Rinse nerves 3 times in 0.1 M working cacodylate buffered solution, 5 min each.
*Can hold here (at 4*C) for a few days if necessary*
5. Dehydrate nerves in Reagent Alcohol:
70% 5 minutes
80% 10 minutes
90% 10 minutes
90% 10 minutes
100% 10 minutes
100% 10 minutes
100% 10 minutes
6. Clear nerves in acetone 2 times, 5 minutes for first exposure, 10 minutes for second.
BEWARE: Use fresh acetone for procedure. Acetone tends to pick up
water overtime, resulting in the formation of micro-pockets of water along
surface of nerve, impeding Epon infiltration.
7. Infiltrate in 1:1 acetone/Epon mixture at room temperature for 5-24 hrs (rotate).
8. Infiltrate in 100% Epon 8 hours at room temperature (rotate).
9. Embed in TEM molds (with fresh 100% Epon).
10. Let cure 24 hours at 60'C in oven (standard pressure).
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Appendix C: Hematoxylin and Eosin (H & E) Staining Protocol
Formalin fixed, paraffin embedded specimens
Solutions
Hematoxylin Harris Hematoxylin Solution, Sigma Cat# HHS-128. F
of stock solution into staining dish.
Eosin Eosin Y Solution Aqueous, Sigma Cat# HT 110-2-128
Acid Alcohol 0.5 % in 80% alcohol (99.5ml of 80% alcohol + 0.5 ml HCl)
Other Materials
Cytoseal Cytoseal 60, Cat# 18006, Electron Microscopy Scien
Methods
1. Deparaffinize and Rehydrate
Xylene (or substitute) 2 x 5 min.
100% alcohol 2 x 3 min.
95% alcohol 2 x 2min.
80% alcohol 1 min.
Wash in tap water 5 min.
2. Hematoxylin, 3 min. Note: be sure to filter hematoxylin prior to us
3. Wash in tap water for 5 min.
4. One quick dip in acid alcohol.
5. Wash in tap water for 5 min.
6. Eosin, 3 quick dips.
7. Dehydrate
100% alcohol 2 x 3 min.
Xylene (or substitute) 2 x 3 min.
8. Coverslip with Cytoseal
ilter 200ml
ces.
e!
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